Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNSNASDAQ:EARNASDAQ:ESTANASDAQ:INGNNASDAQ:SIEN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$12.50+2.1%$12.47$11.75▼$25.36$566.03M1.12381,710 shs435,242 shsEAREargo$70.50$52.85$1.47▼$8.48$1.46B1.523,347 shsN/AESTAEstablishment Labs$43.40+1.6%$35.93$26.56▼$52.41$1.24B0.8473,838 shs423,855 shsINGNInogen$7.10+1.0%$6.64$5.70▼$13.33$189.02M1.66243,837 shs164,174 shsSIENSientra$0.43$0.16▼$4.94$2.08M2.044.15 million shs3.44 million shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical+0.37%+1.32%-2.62%-14.75%-38.50%EAREargo0.00%0.00%0.00%0.00%0.00%ESTAEstablishment Labs+4.35%+16.76%+23.30%+6.48%-6.01%INGNInogen-0.71%+5.40%+9.16%+1.15%-13.53%SIENSientra0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVNSAvanos Medical3.4107 of 5 stars0.03.00.00.02.71.73.8EAREargoN/AN/AN/AN/AN/AN/AN/AN/AESTAEstablishment Labs1.3914 of 5 stars2.41.00.00.02.12.50.6INGNInogen4.2921 of 5 stars3.34.00.03.91.51.71.3SIENSientraN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 0.00N/AN/AN/AEAREargo 0.00N/AN/AN/AESTAEstablishment Labs 2.80Moderate Buy$52.4020.74% UpsideINGNInogen 2.50Moderate Buy$11.0054.93% UpsideSIENSientra 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest EAR, ESTA, INGN, AVNS, and SIEN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/15/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/13/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$48.005/22/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Moderate Buy$12.005/16/2025ESTAEstablishment LabsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$62.005/14/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$48.005/8/2025INGNInogenStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $7.004/14/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold4/9/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$687.80M0.84$12.14 per share1.03$18.03 per share0.69EAREargo$41.11M35.61N/AN/A$4.87 per share14.48ESTAEstablishment Labs$166.02M7.56N/AN/A$1.90 per share22.84INGNInogen$335.70M0.57N/AN/A$7.30 per share0.97SIENSientra$90.55M0.00N/AN/A($0.04) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$392.10M-$8.37N/A7.23N/A-55.80%6.26%4.63%7/30/2025 (Estimated)EAREargo-$157.49M-$7.52N/A∞N/A-263.14%-135.08%-96.37%N/AESTAEstablishment Labs-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)INGNInogen-$35.89M-$1.15N/AN/AN/A-8.08%-14.76%-9.01%8/5/2025 (Estimated)SIENSientra-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/ALatest EAR, ESTA, INGN, AVNS, and SIEN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025ESTAEstablishment Labs-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million5/7/2025Q1 2025INGNInogen-$0.52-$0.25+$0.27-$0.25$79.57 million$82.28 million5/6/2025Q1 2025AVNSAvanos Medical$0.19$0.26+$0.07$0.14$161.75 million$167.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AEAREargoN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/ASIENSientraN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.122.571.56EAREargoN/A3.222.97ESTAEstablishment Labs5.723.362.05INGNInogenN/A3.072.67SIENSientraN/A0.570.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%EAREargo80.53%ESTAEstablishment Labs72.91%INGNInogen89.94%SIENSientra15.38%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.64%EAREargo0.81%ESTAEstablishment Labs11.44%INGNInogen1.46%SIENSientra1.53%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical2,22746.24 million45.02 millionOptionableEAREargo24320.76 million20.59 millionNot OptionableESTAEstablishment Labs1,01828.92 million25.61 millionOptionableINGNInogen1,03026.89 million26.49 millionOptionableSIENSientra30411.96 million11.78 millionOptionableEAR, ESTA, INGN, AVNS, and SIEN HeadlinesRecent News About These CompaniesNeuroPace Hires Former CFO of Staar SurgicalJune 24, 2025 | marketwatch.comSienna Resources Inc. Closes Private PlacementJune 17, 2025 | newsfilecorp.comNSpinning the State: Franklin, Sun Prairie, ClevelandMarch 12, 2025 | wtmj.comWFranklin-based Tiger Aesthetics invests $50M in Franklin manufacturing facilityMarch 7, 2025 | bizjournals.comIndonesia Medical Aesthetics Market Report 2024-2029 - 11.5% CAGR Forecast, with Market Set to Reach USD 495.64 Million by 2029November 6, 2024 | finance.yahoo.comGlobal Cosmetic Implants Market Set to Reach USD 1…November 4, 2024 | pharmiweb.comPGlobal Axillary Hyperhidrosis Treatment Market Projected to Reach USD 3.3 Billion by 2033 at a 6.7% of CAGROctober 29, 2024 | fmiblog.comFButtock Augmentation Market is expected to Grow USD 26.9 Billion by 2032 increase at a CAGR of around 27.4%October 22, 2024 | pharmiweb.comPCosmetic Surgery Market Size Projected to Reach USD 94.5 Billion by 2032 with a CAGR of 5.8% - SNS InsiderOctober 3, 2024 | finance.yahoo.comExtremity Tissue Expanders Market is projected to grow at a CAGR of 6.3% to reach USD 1.84 Billion by 2028October 2, 2024 | fmiblog.comFAesthetic Medicine Market Size to Worth USD 205.32 Billion by 2033August 26, 2024 | finance.yahoo.comGel Implants Market is projected to grow at a 3.8% CAGR and reach USD 1,760 Million by 2033 | FMI StudyAugust 7, 2024 | fmiblog.comFGlobal Cosmetology Market is anticipated to surpass USD 316.05 billion by the year 2033July 22, 2024 | pharmiweb.comPCosmetic Surgery Products Market Set to Reach USD 41.64 Billion by 2033 at a 8.1% of CAGRJuly 19, 2024 | pharmiweb.comPAesthetic Implants Market to Reach USD 10 Billion by 2032 | Market.usMay 29, 2024 | pharmiweb.comPAesthetic Medicine Market Forecast to Reach USD 571.6 Billion by 2033 | Market.usMay 29, 2024 | pharmiweb.comPBreast Implants Market, Projected to Expand at a 7.7% CAGR to 2033May 22, 2024 | pharmiweb.comPGlobal Breast Implant Market Projected to Reach US$ 4.1 Billion by 2032May 15, 2024 | finance.yahoo.comPace Industries in Grafton announces it will lay off 90 workers beginning in JuneMay 9, 2024 | msn.comGlobal Breast Reconstruction Surgery and Treatment Market Will Surge at a CAGR of 5.9% to Reach USD 1.61 Billion By 2033May 8, 2024 | fmiblog.comFNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI Spending3 Companies to Buy on This Early Cycle RecoveryBy Gabriel Osorio-Mazilli | June 3, 2025View 3 Companies to Buy on This Early Cycle RecoveryEAR, ESTA, INGN, AVNS, and SIEN Company DescriptionsAvanos Medical NYSE:AVNS$12.50 +0.26 (+2.13%) Closing price 03:59 PM EasternExtended Trading$12.52 +0.02 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Eargo NASDAQ:EAREargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.Establishment Labs NASDAQ:ESTA$43.40 +0.69 (+1.62%) Closing price 04:00 PM EasternExtended Trading$41.20 -2.20 (-5.07%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Inogen NASDAQ:INGN$7.10 +0.07 (+1.00%) Closing price 04:00 PM EasternExtended Trading$7.12 +0.02 (+0.21%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Sientra NASDAQ:SIENSientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
